Pharmaceutical firm’s compliance program for fair trade loses momentum

Published: 2008-10-02 07:00:00

Updated: 2008-10-02 07:00:00

Efforts of pharmaceutical companies for self-purification to root out illicit practices have lost its early momentum in the face of prevailing irregular business practices, according to pharmaceutical business sources.

One of the things drug makers are famous for is their world of rebates, mon...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK